Matrix stiffness | ECM rigidity | 8.6–55 kPa | FAK/phosphopaxillin/vinculin pathway | Induce migration of mouse embryonic fibroblasts | 57 |
| Matrix rigidity | 1023, 7307, and 22,692 Pa | ROCK signaling | Enhance the invasive migration of cancer cells | 58 |
| Matrix stiffness | 1, 4, and 25 kPa | E-cadherin/β-catenin/YAP/TAZ | Induce EMT and promote chemoresistance in pancreatic cancer cells | 59 |
| Matrix stiffness | 150 and 5700 Pa | TWIST1-G3BP2 | Drive EMT and tumor metastasis of breast tumors | 60 |
| Microenvironmental stiffness | 0.08–119 kPa | EGFR signaling | Enhance glioma cell proliferation | 61 |
Shear stress | Fluid shear | 2 dyne/cm2 | IGF-2 and VEGF signaling pathways | Promote chondrosarcoma cell invasion | 62 |
| Interstitial flow | 0.2 µm/s | CCR7 signaling | Direct tumor cell migration | 32 |
| Interstitial fluid flow | 0.05–0.1 µm/s | CXCR4/CXCL12 and MEK/ERK | Increase invasion of hepatocellular carcinoma cell | 63 |
| Low shear stress | 1.8 dyne/cm2 | FAK/Src and ROCK/p-MLC pathways | Induce breast cancer cell motility and adhesion | 64 |
| Fluid shear stress | 2.25–20 dyne/cm2 | ERK-GSK3β | Promote EMT | 65 |
Compressive stress | Solid stress | 4.0 mm Hg | GDF15/Akt/CREB1 pathway | Induce migration of pancreatic cancer cells | 66 |
| Compressive strains | 1% strain | ERK1/2-RUNX2 | Promote drug resistance of tumor cells | 67 |
| Compressive stress | 10 kPa | p27Kip1 | Inhibit proliferation in tumor spheroids | 68 |